Modern biology, ethics, and the future of medicine

The proliferation of genome-editing techniques such as CRISPR/Cas-9 has led to a resurgence of debate on the ethics and biological consequences of human genome engineering. What was once science fiction is quickly becoming scientific reality because of rapid advances in molecular biology. Along with the potential to unlock secrets of fundamental human biology, these techniques could be used therapeutically in the future. Particularly contentious is the potential to edit the human germline, the DNA we pass onto the next generation. Is it ethical for us to edit gene variations known to cause terminal disease without the consent of future generations? What about inheritable non-life threatening medical conditions? How do we ensure widespread access to these technologies and not allow them to become the toys of the wealthy and elite?
Speakers:
Onora O'Neill
Professor, Faculty of Philosophy, University of Cambridge; Cross-bench member of the House of Lords; Chair of the UK’s Equality and Human Rights Commission.
Lauren Zeitels
Resident Physician at Massachusetts General Hospital, Johns Hopkins School of Medicine; MPhil Medical Genetics (2006)
Michael Young
MPhil Philosophy (2011)
Elizabeth Dzeng
Assistant Professor, Medicine and Social and Behavioural Science, University of California, San Francisco; PhD Public Health and Primary Care (2011)

[@emilyswarr8747]

lol 6:17 😂😂😂

[@BethanyjjZimmerman]

singling out short people, what a shame....

[@skywrss]

lol